Future of drugs-Heart Disease & Stroke_K-134
Drug
Name
|
K-134
|
Structure
|
|
Drug Code
|
K-134
|
Synonym
|
OPC-33509
1-cyclopropyl-1-(2-hydroxycyclohexyl)-3-[3-[(2-oxo-1H-quinolin-6-yl)oxy]propyl]urea
|
Molecular Formula
|
C22H29N3O4
|
Innovator
|
D. Western Therapeutics
Institute
Kowa Company, Ltd.
|
Condition
|
Arteriosclerosis
obliterans
|
Mechanism of Action
|
Type 3 cyclic nucleotide
phosphodiesterase inhibitors (PDE3 inhibitor)
|
Clinical Phase
|
IIb in US
|
Comments
Post a Comment